General Motors Co. and Honda Motor Co. will jointly develop affordable electric vehicles in major global markets, dramatically expanding a partnership that already spans gas-powered models, batteries and self-driving technology. The automakers plan to create a new architecture based on GM's Ultium EV battery that will be used primarily for small crossover SUVs, with the first models available in North America in 2027, they said in a statement Tuesday. The project is intended to produce EVs that will be priced below GM's planned $30,000 Chevrolet Equinox and similar future offerings from Honda, the companies said on a call with journalists. "GM and Honda will share our best technology, design and manufacturing strategies to deliver affordable and desirable EVs on a global scale, including our key markets in North America, South America and China," GM Chief Executive Officer Mary Barra said in the statement. The collaboration marks a major move toward democratizing electric vehicles, most of which are expensive and beyond the reach of many consumers.

Ganesan takes the mystery out of implementing AI, showing leaders how to launch AI initiatives that get results. In The Business Case for AI, Kavita Ganesan takes the mystery out of implementing AI, showing leaders how to launch AI initiatives that get results. With real-world AI examples to spark new ideas, you'll learn how to identify high-impact AI opportunities, prepare for AI transitions, and measure your AI performance. Simple and compelling, The Business Case for AI gives leaders the information they need without the technical jargon. Whether you want to jumpstart your AI strategy, manage AI initiatives for better outcomes, or simply find inspiration for your own AI applications, The Business Case for AI is a blueprint for Business AI success.

Artificial intelligence, machine learning, and advanced analytics are critical to the challenge of producing intelligence from the enormous amounts of data available to the Intelligence Community. This day-long symposium will focus on the challenge of "Big Data" and what the IC needs to do to address it. Panels will examine the IC's AIM Strategy; the importance of the Pentagon's newly created Chief Digital and AI Officer; challenges and success stories with operationalizing AI; and the capabilities needed to make it all work. Media Policy This event is open to the press. Contact [email protected] for more information.

Alphabet's Wing division has announced that it's launching a drone delivery service in the Dallas-Fort Worth (DFW) metroplex on April 7th. "With this service, the DFW area will be the largest metro in the world, and the first in the United States, with access to on-demand drone delivery," a company spokesperson said in an emailed statement. Wing's primary launch customer is Walgreens, which will deliver health and wellness products directly to customer's homes. For that, it will use a new operational model where drones are staged at one of its own store parking lots, rather than a Wing facility. It will also be delivering ice cream from Blue Bell Creameries, Easyvet prescription pet medications (yep) and first aid kits from Texas Health.

Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National Medical Products Administration (NMPA) has cleared the company's investigational new drug application (IND) for AC0682 for the treatment of patients with estrogen receptor (ER)-positive breast cancers. AC0682 is an orally bioavailable chimeric degrader molecule designed to target ERα protein with high potency and selectivity. "Breast cancer is the most common cancer among women in China. We are excited about the IND clearance of AC0682 in China, after its IND clearance and initiation of a Phase 1 study in the US late last year," said Jie Fan, Ph.D., Chief Executive Officer, Accutar Biotechnology, Inc. "We look forward to accelerating the development of AC0682 and furthering our commitment to bringing innovative medicines to patients worldwide." The Phase 1 study in China will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of AC0682 treatment in Chinese patients with ER-positive breast cancer.

The Motion Planning Research team is specialized in fusion of Machine Learning and Classical Methods, researches new deep learning approaches, builds deep neural networks, algorithms, and software to impact across navigation, behavior, route planning, as well as trajectory optimization, numerical optimization, and model predictive control. The team creates proof of concepts and once an idea is effective, works to put then into production. Motional's Machine Learning team has produced ground breaking advancements in the autonomous vehicle industry including nuPlan (https://arxiv.org/abs/2106.11810), Motional is a driverless technology company making self-driving vehicles a safe, reliable, and accessible reality. The Motional team is made up of engineers, researchers, innovators, dreamers and doers, who together are creating a first-of-its-kind technology with the potential to transform the way we move.

Pittsburgh, PA--March 29, 2022: Gather AI, the first truly automated inventory management system that brings near-real-time visibility to warehousing operations, has positively impacted many customers. Small-size physical stores all the way to multinational corporations like Walmart and Amazon depend on reliable and accurate inventory management software systems, as these are needed everywhere, and with even more challenging tasks at large-scale retailers, such as the warehouses from the biggest retailers in the Fortune 500. But, even with inventory management software, large organizations still rely on people on forklifts with barcode readers to perform cycle counts, from a significant amount of employees to costly machinery to properly manage large-scale inventories, such as those found in retail, third-party logistics, food distribution, and warehouses in air cargo industries. Most importantly, the visibility of what's sitting on the DC floor is delayed by 3-4 months. To solve this significant problem, Gather AI is building the world's first truly autonomous inventory management platform, freeing logistic-driven organizations from inefficient and manual tasks through intelligent and robust automation.

Arnav Bawa, a student in the artificial intelligence program at Chandler Gilbert Community College, has developed an AI application to interpret EEG brain wave scans. The application can help predict brain seizures, so a patient can take medication or prevent injury from falling. William Glover, a student in the artificial intelligence program at Chandler Gilbert Community College, has developed an AI application for drones. The application can be used in indoor search and rescue situations. It uses AI to interpret a live video feed to look for and recognize people who may be trapped in a burning building.

StradVision, a company developing AI-powered computer vision technology for autonomous vehicles and advanced driver assist systems (ADAS), announced today that German automotive technology supplier ZF Friedrichshafen AG ("ZF") has acquired a 6% stake in the company. As part of the investment, the two companies will expand their portfolio of perception and safety technology for autonomous vehicles. ZF is one of the world's largest automotive component suppliers. The company's products are found in many vehicles from the world's top automakers, including BMW and Toyota Motor Corp. ZF offers a full portfolio of components and systems for active and passive safety technology, which more recently focuses on the four fields of autonomous driving, electromobility, integrated safety and vehicle motion control, including steering systems. ZF's autonomous driving technology also includes the ZF ProAI high-performance processor and vehicle software supporting ADAS and self-driving functions.

Professor and CADScor System inventor will present on the AI-based CADScor System, a rapid assessment of coronary artery disease. The session will be live broadcast on this link: https://us02web.zoom.us/j/86991641341?pwd WGx2V0c1aXkvbVhBQTdhdWhESGZiUT09. The recording and the presentations will also be available after the event. The information was provided, through the agency of the above contact person, for publication at the time specified by the company's news distributor, GlobeNewswire. About Acarix: Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD).